Alex Spyropoulos Profile
Alex Spyropoulos

@AlexSpyropoul

Followers
1K
Following
60
Media
116
Statuses
475

Thrombosis Expert and Professor of Medicine at Zucker School of Medicine, Northwell Health Systems New York. But also adventurer, father, husband, and Hellene.

New York, USA
Joined July 2017
Don't wanna be here? Send us removal request.
@AlexSpyropoul
Alex Spyropoulos
2 months
High rates of #bleeding in patients on chronic anticoagulants after emergency surgery or index critical site #bleeding: RADOA registry ⁦@Vasculearn⁩ ⁦@AnticoagForum⁩ ⁦@PERTConsortium⁩ ⁦@ThrombosisCan⁩ ⁦@ThrombosisUK⁩ ⁦⁦@EuropeanTHA
Tweet media one
0
3
7
@AlexSpyropoul
Alex Spyropoulos
2 months
No change in post-thrombotic syndrome indices or stent thrombosis with #DOAC vs #DOAC + ASA after venous stent: ARIVA trial ⁦@Vasculearn⁩ ⁦@AnticoagForum⁩ ⁦@PERTConsortium⁩ ⁦@ThrombosisCan⁩ ⁦@ThrombosisUK⁩ ⁦@canvector⁩ ⁦@EuropeanTHA
Tweet media one
0
5
10
@grok
Grok
8 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
416
686
3K
@AlexSpyropoul
Alex Spyropoulos
2 months
Polyvascular disease is associated with ⬆️risk of recurrent pulmonary #embolism in acute PE #ISTH2025@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@thrombosisday⁩ ⁦@AnticoagForum⁩ ⁦@ThrombosisCan⁩ ⁦@ThrombosisUK⁩ ⁦@canvector⁩ ⁦@EuropeanTHA⁩ ⁦
Tweet media one
1
4
13
@AlexSpyropoul
Alex Spyropoulos
2 months
Thrombolysis suggestive of reducing post-#pulmonary embolism syndrome in patients with #DVT #ISTH2025@Vasculearn⁩ ⁦@AnticoagForum⁩ ⁦@PERTConsortium⁩ ⁦@ThrombosisCan⁩ ⁦@canvector⁩ ⁦@ThrombosisUK⁩ ⁦@EuropeanTHA
Tweet media one
0
2
15
@AlexSpyropoul
Alex Spyropoulos
2 months
Cobra Trial: #apixaban safer than #rivaroxaban for venous #thrombosis treatment #ISTH2025@AnticoagForum⁩ ⁦@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@thrombosisday⁩ ⁦@ThrombosisCan⁩ ⁦@canvector⁩ ⁦@EuropeanTHA⁩ ⁦@CMichaelGibson⁩ ⁦
Tweet media one
2
54
155
@AlexSpyropoul
Alex Spyropoulos
2 months
Quite true @CMichaelGibson.
@AlexSpyropoul
Alex Spyropoulos
2 months
Timing initiating #heparin crucial in #pulmonary embolism mortality #ISTH2025@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@AnticoagForum⁩ ⁦@ThrombosisCan⁩ ⁦@thrombosisday⁩ ⁦@canvector⁩ ⁦@EuropeanTHA⁩ ⁦@Medscape⁩ ⁦@ThrombosisUK
Tweet media one
0
0
2
@AlexSpyropoul
Alex Spyropoulos
2 months
Quite true @CMichaelGibson.
@AlexSpyropoul
Alex Spyropoulos
2 months
#LMWH >>> UFH or #DOAC for medical inpatient #thromboprophylaxis with ⬇️ #bleeding: New MA ⁦@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@AnticoagForum⁩ ⁦@ThrombosisCan⁩ ⁦@canvector⁩ ⁦@ThrombosisUK⁩ ⁦@EuropeanTHA⁩ ⁦@thrombosisday⁩ ⁦
Tweet media one
0
0
2
@AlexSpyropoul
Alex Spyropoulos
2 months
RT @AlexSpyropoul: #LMWH >>> UFH or #DOAC for medical inpatient #thromboprophylaxis with ⬇️ #bleeding: New MA ⁦@Vasculearn⁩ ⁦@PERTConsorti….
0
5
0
@AlexSpyropoul
Alex Spyropoulos
2 months
#LMWH >>> UFH or #DOAC for medical inpatient #thromboprophylaxis with ⬇️ #bleeding: New MA ⁦@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@AnticoagForum⁩ ⁦@ThrombosisCan⁩ ⁦@canvector⁩ ⁦@ThrombosisUK⁩ ⁦@EuropeanTHA⁩ ⁦@thrombosisday⁩ ⁦
Tweet media one
0
5
17
@AlexSpyropoul
Alex Spyropoulos
2 months
Therapeutic #anticoagulation ⬇️organ support + mortality and #thrombosis > > incurs bleeding in non critically ill #COVID inpatients: patient-level MA #ISTH2025@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@AnticoagForum⁩ ⁦@ThrombosisCan⁩ ⁦@canvector⁩ ⁦
Tweet media one
0
2
5
@AlexSpyropoul
Alex Spyropoulos
2 months
Timing initiating #heparin crucial in #pulmonary embolism mortality #ISTH2025@Vasculearn⁩ ⁦@PERTConsortium⁩ ⁦@AnticoagForum⁩ ⁦@ThrombosisCan⁩ ⁦@thrombosisday⁩ ⁦@canvector⁩ ⁦@EuropeanTHA⁩ ⁦@Medscape⁩ ⁦@ThrombosisUK
Tweet media one
0
10
28
@AlexSpyropoul
Alex Spyropoulos
2 months
And so it begins. looking forward to #ISTH2025
Tweet media one
0
0
5
@AlexSpyropoul
Alex Spyropoulos
2 months
Tweet media one
1
4
16
@AlexSpyropoul
Alex Spyropoulos
2 months
RT @cardiomet_CE: 1) Welcome to a new #accredited #tweetorial from @cardiomet_ce! This tweetorial is the first of 3⃣ that will address adva….
0
8
0
@AlexSpyropoul
Alex Spyropoulos
3 months
RT @AhmedKo45911157: 📢New 2024 #ASH & #ISTH guidelines for pediatric VTE!.🧒Start with LMWH or UFH based on bleeding risk & renal status.💊Tr….
0
4
0
@AlexSpyropoul
Alex Spyropoulos
3 months
RT @FernandoGLMD: New Article! 🚨. We just published a deep dive into Portal Vein Thrombosis in Patients Without Cirrhosis – exploring real-….
0
3
0
@AlexSpyropoul
Alex Spyropoulos
3 months
Tweet media one
0
3
12
@AlexSpyropoul
Alex Spyropoulos
3 months
Importance of minimizing Type II error and increasing specificity of death in CV trials with composite endpoints! ISTH-defined VTE death is the next step for designing future venous #thrombosis trials: lessons from MARINER @CMichaelGibson @thrombosisday
Tweet media one
0
1
7